as 10-29-2025 4:00pm EST
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
| Founded: | 1886 | Country: | United States |
| Employees: | N/A | City: | NEW BRUNSWICK |
| Market Cap: | 408.0B | IPO Year: | 1944 |
| Target Price: | $196.19 | AVG Volume (30 days): | 8.3M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 10.35 | EPS Growth: | 71.26 |
| 52 Week Low/High: | $140.68 - $194.48 | Next Earning Date: | 10-14-2025 |
| Revenue: | $92,149,000,000 | Revenue Growth: | 5.08% |
| Revenue Growth (this year): | 6.63% | Revenue Growth (next year): | 5.31% |
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| REED JOHN C | JNJ | EVP, Innovative Medicine, R&D | Oct 17 '25 | Sell | $192.71 | 21,721 | $4,185,793.09 | 10,658 | |
| Taubert Jennifer L | JNJ | EVP, WWC. Innovative Medicine | Sep 4 '25 | Sell | $177.81 | 56,471 | $10,040,882.63 | 178,013.001 | |
| Duato Joaquin | JNJ | CEO and Chairman of the Board | Aug 22 '25 | Sell | $179.21 | 125,824 | $22,548,654.81 | 275,967 | |
| Wolk Joseph J | JNJ | Exec VP, CFO | Aug 15 '25 | Sell | $176.91 | 16,820 | $2,975,570.69 | 14,000 |
JNJ Breaking Stock News: Dive into JNJ Ticker-Specific Updates for Smart Investing
Zacks
13 hours ago
MT Newswires
15 hours ago
PR Newswire
17 hours ago
Insider Monkey
a day ago
GlobeNewswire
a day ago
Simply Wall St.
a day ago
The Wall Street Journal
a day ago
Barrons.com
2 days ago
The information presented on this page, "JNJ Johnson & Johnson - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.